JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120115

Camptothecin, DNA topoisomerase inhibitor

Be the first to review this product! Submit a review

|

(3 Publications)

MW 348.4 Da, Purity >98%. Cell-permeable DNA topoisomerase inhibitor. Potent antitumour and antibiotic agent. Achieve your results faster with highly validated, pure and trusted compounds.

View Alternative Names

DNA topoisomerase 1, DNA topoisomerase I, NUP98 fusion gene, TOP I, TOP1_HUMAN, Topoisomerase (DNA) I, Topoisomerase 1, TopoisomeraseI, Type I DNA topoisomerase

4 Images
Immunocytochemistry/ Immunofluorescence - Camptothecin, DNA topoisomerase inhibitor (AB120115)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Camptothecin, DNA topoisomerase inhibitor (AB120115)

ab2893 staining γH2AX (phospho S139) in HeLa cells treated with camptothecin (ab120115), by ICC/IF. Increased nuclear expression of γH2AX (phospho S139) correlates with increased concentration of camptothecin, as described in literature.
The cells were incubated at 37°C for 3h in media containing different concentrations of ab120115 (camptothecin) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab2893 (10 μg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight® 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.

Functional Studies - Camptothecin, DNA topoisomerase inhibitor (AB120115)
  • FuncS

Unknown

Functional Studies - Camptothecin, DNA topoisomerase inhibitor (AB120115)

HeLa cells were incubated at 37°C for 3h with vehicle control (0 μM) and different concentrations of camptothecin (ab120115). Decreased expression of γH2A.X (phospho S139) in HeLa cells correlates with an increase camptothecin concentration, as described in literature.

Whole cell lysates were prepared with RIPA buffer (containing protease inhibitors and sodium orthovanadate), 20 μg of each were loaded on the gel and the WB was run under reducing conditions. After transfer the membrane was blocked for an hour using 5% BSA before being incubated with ab2893 at 1 μg/ml and ab10475 at 1 μg/ml overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP (ab97051) at 1/10000 dilution and visualised using ECL development solution.

Functional Studies - Camptothecin, DNA topoisomerase inhibitor (AB120115)
  • FuncS

Unknown

Functional Studies - Camptothecin, DNA topoisomerase inhibitor (AB120115)

Functional assays : Caspase 3 (active) Red Staining Kit (ab65617)

Caspase 3 activity in Jurkat cells (3 x10e5 cells) following 24 hour exposure to 2 uM Camptothecin (ab120115) with or without 50 μM caspase inhibitor Z-VAD(OMe)-FMK (ab120487). Background signal subtracted, duplicates; +/- SD.

Chemical Structure - Camptothecin, DNA topoisomerase inhibitor (AB120115)
  • Chemical Structure

Lab

Chemical Structure - Camptothecin, DNA topoisomerase inhibitor (AB120115)

2D chemical structure image of ab120115, Camptothecin, DNA topoisomerase inhibitor

Key facts

CAS number

7689-03-4

Purity

>98%

Form

Solid

form

Molecular weight

348.4 Da

Molecular formula

C<sub>2</sub><sub>0</sub>H<sub>1</sub><sub>6</sub>N<sub>2</sub>O<sub>4</sub>

PubChem

24360

Nature

Synthetic

Solubility

Soluble in DMSO to 5 mM

Biochemical name

Camptothecin

Biological description

Cell-permeable DNA topoisomerase inhibitor. Potent antitumour and antibiotic agent.

Canonical smiles

CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O

Isomeric smiles

CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O

InChi

InChI=1S/C20H16N2O4/c1-2-20(25)14-8-16-17-12(7-11-5-3-4-6-15(11)21-17)9-22(16)18(23)13(14)10-26-19(20)24/h3-8,25H,2,9-10H2,1H3/t20-/m0/s1

InChiKey

VSJKWCGYPAHWDS-FQEVSTJZSA-N

IUPAC Name

(19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Topoisomerase I also known as DNA topoisomerase I or Topo I is an important enzyme in the unwinding of the DNA double helix during processes such as replication and transcription. This enzyme has a molecular mass of approximately 91 kDa and functions by creating transient single-strand breaks in the DNA allowing relaxation of supercoils. Topoisomerase I is widely expressed in both proliferating and non-proliferating cells with higher levels seen in tissues with rapid cell division like the gastrointestinal tract and some immune cells.
Biological function summary

Topoisomerase I plays a significant role in the modulation of DNA topology ensuring proper chromosomal functions during cellular proliferation. It serves as a single polypeptide and does not require a companion for its activity unlike other topoisomerases that may function in complexes. The enzyme’s ability to relieve torsional stress in DNA is essential for maintaining genomic stability and facilitating the smooth progression of the replication fork.

Pathways

Topoisomerase I is vital for DNA replication and transcription processes. It works in concert with other proteins such as helicases and ligases to ensure efficient unwinding and rewinding of DNA strands. The enzyme participates in the DNA damage response pathway where it interacts with proteins like PARP1 to coordinate repair processes. Its action is important in both the S phase of the cell cycle where DNA synthesis occurs and in the G0 phase where cells are in a quiescent state.

Topoisomerase I is heavily implicated in oncogenesis with significant associations to colorectal and ovarian cancers. Its heightened activity can lead to genomic instability a hallmark of cancer development. The enzyme also relates to chemotherapeutic resistance where mutations in topoisomerase I lead to reduced drug efficacy. Furthermore inhibitors targeting topoisomerase I such as camptothecin-based drugs exploit its role in cancer aiming to induce DNA damage selectively in rapidly dividing cells. Connections to other proteins like BRCA1 are apparent in these pathways as they both contribute to the DNA repair processes in cells.

Product protocols

Publications (3)

Recent publications for all applications. Explore the full list and refine your search

Cell death discovery 11:31 PubMed39875375

2025

PARP inhibition-associated heterochromatin confers increased DNA replication stress and vulnerability to ATR inhibition in SMARCA4-deficient cells.

Applications

Unspecified application

Species

Unspecified reactive species

Kimiyoshi Yano,Megumi Kato,Syoju Endo,Taichi Igarashi,Ryoga Wada,Takashi Kohno,Astrid Zimmermann,Heike Dahmen,Frank T Zenke,Bunsyo Shiotani

Proceedings of the National Academy of Sciences of the United States of America 118: PubMed33707212

2021

Super-resolution mapping of cellular double-strand break resection complexes during homologous recombination.

Applications

Unspecified application

Species

Unspecified reactive species

Donna R Whelan,Eli Rothenberg

PLoS genetics 16:e1009256 PubMed33370257

2020

Super-resolution visualization of distinct stalled and broken replication fork structures.

Applications

Unspecified application

Species

Unspecified reactive species

Donna R Whelan,Wei Ting C Lee,Frances Marks,Yu Tina Kong,Yandong Yin,Eli Rothenberg
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com